# Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen

> **NCT01719133** · PHASE1 · COMPLETED · sponsor: **Anergis** · enrollment: 20 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** placebo
- **DRUG:** Histamine
- **DRUG:** AllerT1
- **DRUG:** AllerT2
- **DRUG:** AllerT3
- **DRUG:** AllerT4
- **DRUG:** AllerT5
- **DRUG:** mix of AllerT1-T2-T3
- **DRUG:** mix of AllerT4-T5

## Key facts

- **NCT ID:** NCT01719133
- **Lead sponsor:** Anergis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-03
- **Final completion:** 2008-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01719133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01719133, "Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01719133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
